Dosimetric advantages of adaptive IMPT vs. Enhanced workload and treatment time - A need for automation.

Head and neck cancer Inter-fraction motion Plan library Treatment planning adaptive radiotherapy (ART) intensity modulated proton therapy (IMPT)

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 25 04 2024
revised: 19 09 2024
accepted: 23 09 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 29 9 2024
Statut: aheadofprint

Résumé

In head-and-neck IMPT, trigger-based offline plan adaptation (Offline Alternative strategies included weekly offline re-planning (Offline Both for coverage and NTCPs, fast Online Online adaptive strategies could approach dosimetric quality of full re-planning at the cost of additional workload and prolonged treatment time compared to the current offline adaptive strategy. Automation needs to play a key role in making more complex adaptive approaches feasible.

Identifiants

pubmed: 39343389
pii: S0167-8140(24)03526-6
doi: 10.1016/j.radonc.2024.110548
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110548

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michelle Oud (M)

Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, Rotterdam, Netherlands; HollandPTC, Delft, Netherlands. Electronic address: m.oud@erasmusmc.nl.

Sebastiaan Breedveld (S)

Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, Rotterdam, Netherlands.

Marta Giżyńska (M)

HollandPTC, Delft, Netherlands.

Yi Hsuan Chen (Y)

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Netherlands.

Steven Habraken (S)

HollandPTC, Delft, Netherlands; Leiden University Medical Center, Department of Radiation Oncology, Leiden, Netherlands.

Zoltán Perkó (Z)

Delft University of Technology, Faculty of Applied Sciences, Department of Radiation Science and Technology, Netherlands.

Ben Heijmen (B)

Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, Rotterdam, Netherlands.

Mischa Hoogeman (M)

Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, Rotterdam, Netherlands; HollandPTC, Delft, Netherlands.

Classifications MeSH